IntrinsicIntrinsic
← Scroll for more →

Hercules Capital, Inc. (HCXY)

Latest Price
$24.03
Market Cap
$4.56B
TTM P/E
12.78
Earnings Yield
7.82%
TTM Div Yield
--
P/B Ratio
1.93
Price at the 2026-11-06 close. Earnings yield is trailing 12-month earnings divided by price.
1-Year Change
-4.91%
52-Week High
$25.62
52-Week Low
$23.52
Daily close, 2025-11-06 to 2026-11-06
Quarter endingDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Last 4 quarters
Net income$120.18M$90.96M$41.85M$68.71M$61.44M$50.34M$78.89M$119.69M$90.83M$42.50M$130.18M$93.57M$357.08M
Operating cash flow$130.88M-$240.89M$59.49M$92.56M-$29.24M-$222.20M-$144.82M-$3.17M-$55.61M-$230.63M$297.92M-$165.64M-$153.96M

Chart: net income per quarter, Dec 2023 to Sep 2026. Hover over or tap a row to chart it.

Recent Material Events

all events →
  1. Hercules Capital declared a third quarter 2026 total cash distribution of $0.47 per share, comprised of a $0.40 base and $0.07 supplemental component, payable November 17 to holders of record on November 10. The company also reported Q3 2026 financial results showing net investment income (NII) of $87.3 million, or $0.47 per share, providing 118% coverage of the base cash distribution. Year-to-date new debt and equity commitments reached a record $3.44 billion, an increase of 20.0% year-over-year, while total fundings rose 9.9% to $1.93 billion. The company operates as a leading specialty finance provider focused on senior secured venture growth loans to innovative technology and life sciences companies.
  2. Hercules Capital, Inc. announced the closing of a public offering on October 8, 2026, issuing $400 million in aggregate principal amount of 6.700% Notes due 2029. The notes mature on October 8, 2029, and pay interest semiannually on April 8 and October 8, commencing April 8, 2027. These unsecured obligations rank senior in right of payment to existing subordinated debt but are structurally junior to secured indebtedness. The company intends to use the net proceeds to repay outstanding unsecured and secured indebtedness, fund investments consistent with its objectives, and for general corporate purposes. Hercules Capital operates as a business development company focused on providing financing solutions to small and mid-sized technology and life science companies.
  3. Hercules Capital, Inc. entered into an Eleventh Supplemental Indenture on July 24, 2026, to issue $325,000,000 in aggregate principal amount of 6.300% Notes due 2031. The notes are unsecured obligations that rank senior in right of payment to all existing and future subordinated indebtedness. Interest is payable semiannually on January 24 and July 24, starting in 2027. The company expects to use the net proceeds to repay debt and fund investments. Hercules Capital, Inc. is a business development company that provides debt financing to middle-market companies.